| 1118 |
Centers for Disease Control and Prevention |
Html |
en |
Trends in Foodborne Illness in the United States, 2013 | CDC Features |
The nation’s food safety grades are out and the results are mixed. CDC’s annual report shows that foodborne infections continue to be an important public health problem in the United States. More can be done. |
| CDC.gov Current Features | 0.906892 |
|
|
CLICK HERE |
| 5365 |
Centers for Disease Control and Prevention |
Html |
en |
Report Finds Global Smokers Consider Quitting due to Graphic Health Warnings on Packages - Press Release: May 26, 2011 |
Report Finds Global Smokers Consider Quitting due to Graphic Health Warnings on Packages |
| tobacco product packages | 0.75055 |
| Mortality Weekly Report | 0.646892 |
| CDC Foundation | 0.520783 |
| adult usage | 0.524155 |
| international partners | 0.520965 |
| package warning | 0.542571 |
| World No Tobacco | 0.756965 |
| urgent action | 0.519934 |
| tobacco | 0.898975 |
| representative household survey | 0.590639 |
| public acceptance | 0.520505 |
| Hopkins Bloomberg School | 0.596194 |
| national governments | 0.518477 |
| Reduce Tobacco | 0.65418 |
| World Health Organization | 0.993101 |
| comprehensive tobacco control | 0.836638 |
| pictorial warnings | 0.784008 |
| MPOWER package | 0.540578 |
| countries | 0.611383 |
| Tobacco Day—an | 0.667379 |
| Effective warning labels | 0.658231 |
| World Lung Foundation | 0.602118 |
| mass media campaigns | 0.597118 |
| global public health | 0.648075 |
| Tobacco Free Kids | 0.741601 |
|
| 14-nation study | 0.533061 |
| tobacco-related health information | 0.641508 |
| CDC director Thomas | 0.640025 |
| Russian Federation | 0.626485 |
| malaria combined—and | 0.519073 |
| graphic health warnings | 0.729273 |
| tobacco advertising | 0.67 |
| percent | 0.648219 |
| electronic data collection | 0.622445 |
| face-to-face personal interviews | 0.624282 |
| additional countries | 0.540034 |
| public awareness | 0.52168 |
| tobacco initiation | 0.670209 |
| Tobacco Free Initiative | 0.747287 |
| global tobacco | 0.679114 |
| Global Adult Tobacco | 0.804341 |
| impact cost-effective initiatives | 0.597652 |
| R. Frieden | 0.526599 |
| health warnings | 0.822697 |
| World Health Assembly | 0.646442 |
| cigarette packages | 0.530572 |
| prompt smokers | 0.536251 |
| GATS | 0.513985 |
| package warnings | 0.711812 |
|
CLICK HERE |
| 5564 |
Centers for Disease Control and Prevention |
Html |
en |
Caprolactam - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9433 |
Centers for Disease Control and Prevention |
Html |
es |
Evaluación del conocimiento sobre las pruebas de detección del cáncer colorrectal en ferias indígenas |
null |
| Weinstein N | 0.592013 |
| MartÃnez ME | 0.591352 |
| Sanderson PR | 0.595147 |
| menor conocimiento | 0.558233 |
|
| tribu navajo | 0.978392 |
| origen navajo | 0.947758 |
| Estados Unidos | 0.520132 |
| Chronic Dis | 0.589765 |
|
CLICK HERE |
| 9866 |
Centers for Disease Control and Prevention |
Html |
en |
PEP 101 - HIV Basics |
Basic questions and answers on HIV post-exposure prophylaxis or PEP. |
| emergency room doctor | 0.479453 |
| pre-exposure prophylaxis | 0.309873 |
| health care provider | 0.534718 |
| safety devices | 0.251979 |
| right way | 0.25244 |
| CDC’s HIV | 0.583235 |
| possible HIV exposure | 0.453463 |
| HIV status | 0.385945 |
| potential HIV exposure | 0.435729 |
| post-exposure prophylaxis | 0.332667 |
| needs | 0.26027 |
| contact information | 0.248884 |
| nPEP guidelines | 0.257605 |
| HIV Risk Reduction | 0.788854 |
| free PEP medicines | 0.417362 |
| CDC fact sheet | 0.300618 |
| HIV medicines | 0.418697 |
| HIV prevention methods | 0.42195 |
| around-the-clock advice | 0.251853 |
| high risk | 0.250097 |
| local medical attention | 0.287249 |
| sex partners | 0.251575 |
| HIV exposure | 0.456801 |
| clinical care costs | 0.290848 |
|
| antiretroviral medicines | 0.323262 |
| Risk Reduction Tool | 0.689076 |
| occupational exposure | 0.278445 |
| brand name Truvada | 0.249065 |
| recent possible exposure | 0.690118 |
| special phone lines | 0.287432 |
| New HIV Infections | 0.440563 |
| medical attention | 0.301872 |
| potential exposure | 0.278341 |
| health care workers | 0.427456 |
| ongoing risk | 0.248072 |
| health care | 0.805035 |
| medication assistance programs | 0.286588 |
| workplace health insurance | 0.287475 |
| health care worker | 0.553277 |
| sterile needles | 0.251238 |
| Exposed health care | 0.314515 |
| PrEP | 0.251222 |
| emergency situations | 0.355821 |
| BETA | 0.26021 |
| HIV | 0.945614 |
| injection practices | 0.251729 |
| PEP | 0.892571 |
| information | 0.296973 |
|
CLICK HERE |
| 9869 |
Centers for Disease Control and Prevention |
Html |
en |
Travelers' Health - Division of Global Migration and Quarantine (DGMQ) - NCEZID |
null |
| vaccine recommendations | 0.554088 |
| monitors data sources | 0.361366 |
| travel-related disease information | 0.447998 |
| travel health risks | 0.519051 |
| health alerts | 0.360099 |
| Uses GeoSentinel data | 0.363324 |
| Health Branch | 0.470379 |
| travel-related health information | 0.497666 |
| monitoring travel-related illnesses | 0.392662 |
| emergency response workers | 0.383244 |
| U.S. yellow fever | 0.551798 |
| globally mobile populations | 0.362015 |
| International Travel | 0.423698 |
| yellow fever vaccine | 0.999511 |
| health care providers | 0.960775 |
| CDC Health Information | 0.636337 |
| Conducts audience research | 0.36037 |
| travel health advice | 0.533034 |
| pre-travel health care | 0.479693 |
| global emergency response | 0.404969 |
| travel health messages | 0.500451 |
| Yellow Book | 0.536849 |
| global public health | 0.512694 |
| health communication | 0.452518 |
|
| yellow fever vaccination | 0.552846 |
| Education Team informs | 0.379702 |
| health threats | 0.385517 |
| disease outbreaks | 0.396242 |
| travel medicine | 0.489279 |
| travel medicine clinics | 0.432581 |
| special needs travelers | 0.488295 |
| travel health | 0.676438 |
| destination-specific recommendations | 0.344183 |
| Oxford University Press | 0.380147 |
| GeoSentinel Network Surveillance | 0.360851 |
| U.S. residents | 0.326071 |
| government travel health | 0.498333 |
| travel health guidance | 0.497286 |
| fever regulatory responsibilities | 0.439731 |
| U.S. travel medicine | 0.460291 |
| Professionals Advising Travelers | 0.486248 |
| travel notices | 0.34725 |
| tropical medicine clinics | 0.368266 |
| H1N1 influenza pandemic | 0.382493 |
| international travelers | 0.436457 |
| travel health recommendations | 0.641332 |
| global yellow fever | 0.54863 |
| fever vaccine safety | 0.498233 |
|
CLICK HERE |
| 11157 |
Centers for Disease Control and Prevention |
Html |
en |
Additional Transplant Related Organizations |
CDC – Information to help make organ and tissue transplants the highest quality possible so that recipients have the best outcomes. |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 12926 |
Centers for Disease Control and Prevention |
Video |
en |
Concussion Videos - What Is A Concussion? |
null |
|
|
CLICK HERE |
| 15996 |
Centers for Disease Control and Prevention |
Html |
en |
Collecting & Submitting Fetal Tissue Specimens for Zika Virus Testing | Zika virus |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| Pathologic Evaluation | 0.388427 |
| infant death | 0.390008 |
| formalin-fixed wet tissues | 0.56903 |
| CDC Form | 0.428563 |
| wet tissues | 0.614442 |
| final surgical pathology | 0.405112 |
| fetal membranes | 0.458394 |
| Body Fluid Specimens | 0.440722 |
| zika virus testing | 0.941554 |
| gestational age | 0.386268 |
| Possible Infectious Etiologies | 0.384397 |
| test results | 0.381764 |
| formalin-fixed tissues | 0.455163 |
| tissues | 0.64315 |
| early pregnancy loss/miscarriage | 0.378511 |
| formalin-fixed specimens | 0.389394 |
| Zika biosafety guidelines | 0.399771 |
| pathology reports results | 0.395542 |
| Test Order Code | 0.380785 |
| fixed tissues | 0.477854 |
| specimen identification numbers | 0.398273 |
| Diseases Pathology Branch | 0.400793 |
| specimen submission paperwork | 0.399758 |
| Zika virus immunohistochemistry | 0.436753 |
| body fluid analysis | 0.386069 |
|
| placental disk | 0.406696 |
| maternal Zika virus | 0.458528 |
| surgical pathology | 0.515407 |
| Zika testing results | 0.406816 |
| possible zika virus | 0.520146 |
| fetal tissues | 0.502489 |
| infant Zika virus | 0.478557 |
| formalin-fixed paraffin-embedded tissue | 0.475008 |
| placental tissues | 0.474188 |
| Zika virus infection | 0.443877 |
| infant autopsy report | 0.423751 |
| local health department | 0.391756 |
| Health Care Providers | 0.392259 |
| paraffin-embedded tissue blocks | 0.470939 |
| infant autopsy tissue | 0.472396 |
| umbilical cord | 0.387281 |
| tissue specimens | 0.454633 |
| infant autopsy tissues | 0.627955 |
| frozen tissues | 0.459001 |
| specimens | 0.47701 |
| formalin-fixed paraffin-embedded tissues | 0.49478 |
| birth anthropometric measurements | 0.380022 |
| healthcare provider | 0.381483 |
| Fetal loss | 0.408667 |
|
CLICK HERE |
| 15999 |
Centers for Disease Control and Prevention |
Html |
en |
Guidance for U.S. Laboratories Testing for Zika Virus Infection |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| Healthcare Providers Caring | 0.290887 |
| FDA-authorized Zika virus | 0.285019 |
| additional NAT testing | 0.29024 |
| symptom onset | 0.33295 |
| congenital zika virus | 0.325714 |
| recent Zika virus | 0.313909 |
| pregnant women | 0.498587 |
| zika virus exposure | 0.444687 |
| virus IgM assay | 0.327838 |
| Updated Interim Guidance | 0.289268 |
| Zika virus results | 0.293976 |
| non-negative IgM serology | 0.288224 |
| symptomatic pregnant women | 0.306625 |
| virus testing requests | 0.285645 |
| IgM antibodies | 0.287247 |
| zika virus infection | 0.763316 |
| Zika virus RNA | 0.29163 |
| IgM assay result | 0.285015 |
| virus NAT testing | 0.320315 |
| testing | 0.475221 |
| dengue virus | 0.373561 |
| Zika virus infection* | 0.286558 |
| Zika virus EUAs | 0.309135 |
| asymptomatic pregnant women | 0.316891 |
| dengue virus IgM | 0.35082 |
|
| Zika IgM assay | 0.298175 |
| IgM serology testing | 0.367277 |
| possible zika virus | 0.395615 |
| 12 weeks after symptom onset | 0.297594 |
| IgM serology result | 0.288875 |
| United States | 0.298599 |
| dengue virus serology | 0.30966 |
| chikungunya virus | 0.298251 |
| Zika virus cases | 0.299357 |
| IgM | 0.401535 |
| IgM serology | 0.38366 |
| NAT testing | 0.38843 |
| zika virus | 0.944017 |
| dengue virus infection | 0.295118 |
| virus IgM testing | 0.333759 |
| previous Zika virus | 0.288761 |
| repeat NAT testing | 0.338116 |
| Zika virus IgM | 0.330817 |
| virus IgM serology | 0.33011 |
| West Nile virus | 0.303031 |
| negative IgM result | 0.28491 |
| Dengue IgM testing | 0.296325 |
| Zika virus testing | 0.4028 |
| asymptomatic non-pregnant individuals | 0.295221 |
|
CLICK HERE |